Check Capital Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$255K Hold
1,300
0.01% 47
2025
Q4
$226K Hold
1,300
0.01% 47
2025
Q3
$248K Hold
1,300
0.01% 46
2025
Q2
$234K Hold
1,300
0.01% 48
2025
Q1
$220K Sell
1,300
-135
-9% -$22.2K 0.01% 47
2024
Q4
$216K Hold
1,435
0.01% 45
2024
Q3
$223K Sell
1,435
-488
-25% -$72.9K 0.01% 47
2024
Q2
$263K Sell
1,923
-133,522
-99% -$18.3M 0.01% 39
2024
Q1
$18M Sell
135,445
-13,707
-9% -$1.78M 0.59% 15
2023
Q4
$20.6M Sell
149,152
-18,578
-11% -$2.44M 0.75% 14
2023
Q3
$20.4M Sell
167,730
-10,356
-6% -$1.38M 0.78% 14
2023
Q2
$25M Sell
178,086
-4,790
-3% -$660K 0.99% 12
2023
Q1
$25.9M Buy
182,876
+3,676
+2% +$526K 1.15% 12
2022
Q4
$28M Buy
179,200
+493
+0.3% +$70.8K 1.35% 12
2022
Q3
$21.9M Buy
178,707
+569
+0.3% +$74.9K 1.17% 15
2022
Q2
$23.7M Sell
178,138
-1,265
-0.7% -$172K 1.18% 13
2022
Q1
$24.6M Buy
179,403
+1,229
+0.7% +$171K 0.96% 16
2021
Q4
$30.8M Sell
178,174
-542
-0.3% -$82.5K 1.29% 14
2021
Q3
$26M Sell
178,716
-2,762
-2% -$404K 1.21% 16
2021
Q2
$23.9M Buy
181,478
+14,938
+9% +$1.96M 1.08% 17
2021
Q1
$21.4M Sell
166,540
-999
-0.6% -$123K 1.04% 19
2020
Q4
$20M Sell
167,539
-5,614
-3% -$684K 1.09% 18
2020
Q3
$19.8M Buy
+173,153
New +$20.5M 1.21% 15

Other funds holding DGX

Check Capital Management's DGX Position: Q1 2026 in Review

Check Capital Management held its Quest Diagnostics (DGX) position steady in Q1 2026 at 1,300 shares worth $255K. The position accounts for 0.01% of the portfolio, ranked #47.

Check Capital Management first reported a position in DGX in Q3 2020 and has held it in 23 quarters since. The position peaked at $30.8M in Q4 2021. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Check Capital Management held 1,300 shares of Quest Diagnostics worth $255K as of Q1 2026.
  • Check Capital Management left its Quest Diagnostics share count unchanged in Q1 2026.
  • Quest Diagnostics made up 0.01% of Check Capital Management's portfolio in Q1 2026, its #47 holding.
  • Check Capital Management first reported a position in Quest Diagnostics in Q3 2020 and has held it in 23 quarters since.
  • Check Capital Management's Quest Diagnostics position peaked at $30.8M in Q4 2021.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Check Capital Management's 13F filing for Q1 2026, filed 4 May 2026.